NetworkNewsBreaks – CytoDyn Inc. (CYDY) Interim CMO to Present at 11th Annual Conference on Stem Cell and Regenerative Medicine

CytoDyn Inc. (OTCQB: CYDY), a biotechnology company developing innovative treatments for multiple therapeutic indications, this morning announced that Richard G. Pestell, M.D., Ph.D., president of the Pennsylvania Cancer and Regenerative Medicine Research Center, distinguished professor at the Baruch S. Blumberg Institute and interim chief medical officer of CytoDyn, will deliver the keynote plenary speech at the 11th Annual Conference on Stem Cell and Regenerative Medicine in Helsinki, Finland. Pestell’s presentation, titled ‘Cancer stem cells, genetic drivers and therapeutic targeting via CCR5’, is scheduled to take place on Monday, October 15, from 10-11 am EEST. Pestell will present recent scientific evidence demonstrating the effectiveness of PRO 140 (leronlimab), which is shown to bind to CCR5 in human breast cancer, block CCR5 signaling induced by cytokines and block human breast cancer cell invasion.

To view the full press release, visit http://nnw.fm/SgzM0

About CytoDyn

CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells.  The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The Company plans to seek FDA approval for PRO 140 in combination therapy and plans to complete the filing of a Biological License Application (BLA) in the first quarter of 2019 for that indication. CytoDyn is also conducting a Phase 3 investigative trial with PRO 140 as a once-weekly monotherapy for HIV-infected patients, and plans to initiate a registration-directed study of PRO 140 monotherapy indication, which if successful, could support a label extension. Clinical results to date from multiple trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV with no reported drug-related serious adverse events (SAEs). Moreover, results from a Phase 2b clinical trial demonstrated that PRO 140 monotherapy can prevent viral escape in HIV-infected patients, with some patients on PRO 140 monotherapy remaining virally suppressed for more than four years. CytoDyn is also conducting a Phase 2 trial to evaluate PRO 140 for the prevention of GvHD and expects to initiate clinical trials with PRO 140 in metastatic triple-negative breast cancer in 2018. For more information, visit the company’s website at www.CytoDyn.com

More from NetworkNewsBreaks

NetworkNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Adds Taxation Reporting Technology to its Proprietary Compliance Platform NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Announces Results of Independent Studies Supporting Restart of Canadian Refinery NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Ships Initial Purchase Order from the NSLC

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.

More News From Asean Coverage

Hong Kong marchers gather as protester's death mourned

Jun 16, 2019

HONG KONG — Hong Kong residents were gathering Sunday for another massive protest over an unpopular extradition bill that has highlighted the territory's apprehension about relations with mainland China, a week after the crisis brought as many as 1 million into the streets. A steady stream of mourners were stopping by a makeshift memorial, meanwhile, to lay flowers and pray for a man who fell to his death Saturday after hanging a protest banner. The man slipped from the grasp of rescuers after clinging for a time to scaffolding outside a shopping mall. He missed a big cushion set up...

The Latest: Hong Kong leadership meets as protests loom

Jun 16, 2019

HONG KONG — The Latest on protests in Hong Kong against extradition bill (all times local): 11:30 a.m. Hong Kong's chief executive has met with her Executive Council as pressure mounts for her to delay or withdraw an unpopular extradition bill. Carrie Lam, who was appointed by Beijing, is expected to speak with media later Saturday. TV networks showed members of the Executive Council, or cabinet, headed by car into a government compound. Some Executive Council members have urged Lam to suspend debate on the bill, which would allow Hong Kong suspects to be tried in mainland China. Another mass...

Hong Kong on edge as pressure grows to delay fugitive bill

Jun 16, 2019

HONG KONG — Pressure on Hong Kong's chief executive Carrie Lam has been mounting, with signs emerging that she may delay an unpopular extradition bill that has drawn hundreds of thousands of people into the streets in protest. Reports say Lam is expected to make an announcement Saturday after talks that continued late into Friday night. Another mass protest is expected Sunday. The pressure on Lam to withdraw the bill is intense, with many protesters demanding she quit. The Beijing-appointed leader of the former British colony is caught between a public anxious to protect civil liberties and legal protections guaranteed...

The Latest: Hong Kong protesters sing hymns, slam violence

Jun 16, 2019

HONG KONG — Latest on the protests in Hong Kong over proposed extradition legislation (all times local): 7:10 p.m. Hong Kong protesters are singing hymns and holding up signs criticizing police violence a day after street clashes left dozens injured. The protesters stood for hours Thursday on a downtown pedestrian bridge, singing "Sing Hallelujah to the Lord," and holding signs that read, "No violence against HK people" and "Stop shooting." Most appeared to be students. Some but not all were wearing face masks, perhaps to obscure their identities after authorities warned protesters might be risking trouble over their activities. Elsewhere,...

China's trade rep says 'external pressures' can help economy

Jun 16, 2019

BEIJING — Chinese media say the country's top trade negotiator has told a forum in Shanghai that "external pressures" can help the economy. Hong Kong's South China Morning Post and mainland Chinese media outlets reported Thursday that Vice Premier Liu He described the pressures that China is currently facing as an "inevitable test." He said the pressures "will help us improve innovation and self-development, speed up reform and opening up, and push forward with high-quality growth." The South China Morning Post says he did not directly reference the U.S.-China trade dispute. The U.S. has accused China of stealing trade secrets...